---
title: "ABL Diagnostics notifies Advanced Biological Laboratories beneficial stake at 93.58%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292921679.md"
description: "ABL Diagnostics announced that Advanced Biological Laboratories reduced its stake in the company to 93.58% of capital on July 6, 2026, following an off-market share sale. The holding decreased to 15,079,346 shares, while voting rights remained at 95.94%."
datetime: "2026-07-16T14:34:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292921679.md)
  - [en](https://longbridge.com/en/news/292921679.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292921679.md)
generator: "portal-rs"
---

# ABL Diagnostics notifies Advanced Biological Laboratories beneficial stake at 93.58%

-   Advanced Biological Laboratories cut its stake in ABL Diagnostics below the 95% capital threshold on July 6, 2026. \* Holding fell to 15,079,346 shares, equal to 93.58% of capital. \* Voting rights stood at 29,593,719, representing 95.94% of voting rights. \* Move followed an off-market share sale. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABL Diagnostics SA published the original content used to generate this news brief on July 16, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ABL.US](https://longbridge.com/en/quote/ABL.US.md)

## Related News & Research

- [Bioretec hosts media event highlighting 500,000 Activa bioresorbable orthopedic implants sold worldwide](https://longbridge.com/en/news/297047388.md)
- [Quest Diagnostics teams with Humanity to offer biological age analysis on Questhealth.com](https://longbridge.com/en/news/296926398.md)
- [SalMar – Record-strong biological performance](https://longbridge.com/en/news/296859687.md)
- [Lexaria says DehydraTECH 3.0 retatrutide tablet boosts absorption up to 4,552% in dog study](https://longbridge.com/en/news/296793626.md)
- [11:00 ETCizzle Bio Highlights CIZ1B Biomarker Blood Test for Lung Cancer at Next Generation Dx Summit](https://longbridge.com/en/news/297064751.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**